Rumana Sultana, MD
Hematology & Oncology · Ridgewood, NJNPI 1215274949
Payments from drug & device makers
Across 11 payments — averaging $15.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$41
- AbbVie$30
- Daiichi Sankyo Inc.$24
- Takeda Pharmaceuticals U.S.A., Inc.$21
- AstraZeneca$15
- E.r. Squibb & Sons, L.L.C.$15
- plus $23 from 2 others
What the payments were for
- Food & beverage$169100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $41 |
| AbbVie | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| AstraZeneca | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Incyte Corporation | 1 | $12 |
| Lilly USA, LLC | 1 | $11 |
How this compares
$169 in reported general payments places this provider in the 10th percentile of 362 hematology & oncology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImbruvicaIbrutinib | 27 | $439,893 |
| ScemblixAsciminib Hydrochloride | 12 | $257,592 |
| TasignaNilotinib Hcl | 12 | $248,220 |
| EliquisApixaban | 20 | $14,524 |
| XareltoRivaroxaban | 11 | $13,334 |
| Exemestane | 12 | $993 |
| Hydroxyurea | 32 | $647 |
| Prednisone | 29 | $146 |
| Letrozole | 22 | $145 |
| Warfarin Sodium | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Ridgewood
- Bruno FangEast Brunswick$8.5M
- Charles FarberMorristown$4.6M
- Rajat BannerjiNew Brunswick$3.3M
- Eleonora TeplinskyParamus$2.6M
- Mohamad CherryMorristown$1.9M
- Evan NaylorManahawkin$1.3M
- James OrsiniBelleville$1.3M
- Eli KirshnerWestwood$1.2M
- Linda DanieuLivingston$1.2M
- Steven PapishMorristown$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.